Funded by the European Union - NextGenerationEU Program
    MUR PNRR    PNRR Italia Domani

(<b style=color:#FF0000>SCADUTO</b>) Cascade Open Call 2023 for Research Node 5 - MEDICINAL CHEMISTRY TECHNOLOGIES FOR THE DEVELOPMENT OF INNOVATIVE ANTIVIRALS

(SCADUTO) Cascade Open Call 2023 for Research Node 5 - MEDICINAL CHEMISTRY TECHNOLOGIES FOR THE DEVELOPMENT OF INNOVATIVE ANTIVIRALS

(SCADUTO) Cascade Open Call 2023 for Research Node 5 - MEDICINAL CHEMISTRY TECHNOLOGIES FOR THE DEVELOPMENT OF INNOVATIVE ANTIVIRALS


This call was published by Spoke 5: Consiglio Nazionale delle Ricerche. - The available budget for this call is of EUR 2'000'000.00.
Support during collection of Applications and Evaluations is provided by the INF-ACT Foundation.

Evaluation of the applications received is in progress



CALL DESCRIPTION AND OBJECTIVES

We invite researchers from public and private research institutions to submit innovative research projects based on the application of various approaches and medicinal chemistry technologies for the design and synthesis of small molecules with antiviral activity. Interdisciplinary public-private collaborations are encouraged.


Projects responding to this call should aim at discovering and optimizing broad-spectrum antivirals, focusing on targeted inhibition of cellular and viral targets to address emerging and pre-existing viral diseases.


Expected Results: New pharmacological tools, or their combinations, which, through targeted inhibition of molecular targets, demonstrate antiviral properties against respiratory or vector-borne viruses.




ELIGIBILITY CRITERIA:




HOW TO APPLY


The call text (in Italian) has been published on the CNR website.
Collection of applications started at 9:00 AM on Oct 11, 2023 and closed at 12:00 PM on Nov 13, 2023

If you have questions or need more information about the application process, write to calls@inf-act.it.




FREQUENTLY-ASKED QUESTIONS


Frequently-asked questions (FAQs) are published here. Due to frequent updates, FAQs are published only in Italian. If translations are required, please send us a message to calls@inf-act.it. Check this page frequently.


Documentazione da Presentare
Soggetti Ammissibili
Durata del Progetto
Partnership con la Fondazione INF-ACT
Costi ammissibili e modalità di rendicontazione
Reclutamento personale a T.D. su fondi di progetto
Cofinanziamento
Quota 40% nel Mezzogiorno
Numero di progetti Finanziati



REPORTING AND OTHERS



EVALUATION PROCESS

Proposals will be evaluated on the basis of the following evaluation criteria:

Proposals will be considered admissible for financing if they obtain at least 70 out of 100 points. Evaluation will be carried out by a panel of 3-5 international and highly-qualified scientists, who are not directly involved in the INF-ACT Research Program. Reviewers will sign a declaration to exclude possible conflicts of interest before accessing the scientific proposals to be evaluated.




INF-ACT partner institutions involved: CNR


INF-ACT Research Nodes involved: RN5


Tags: Research, Grants, Cascade Open Calls

Last update: 11/10/2023


Back to previous page - List of INF-ACT Calls and Opportunities
 

INF-ACT is a Participated Foundation (Fondazione di Partecipazione)
Codice Fiscale 96084470184 - Partiva IVA 02894510185
Address: Corso Strada Nuova, 65 - 27100 Pavia (Italy)
Contact e-mail: management@inf-act.it - PEC: inf-act@pec.it

Fondazione Trasparente - Privacy & Cookies


The INF-ACT Foundation is the Hub of the a project funded under the National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3 - Call for tender No. 341 of 15 March 2022 of Italian Ministry of University and Research funded by the European Union - NextGenerationEU; Project code PE00000007, Concession Decree No. 1554 of 11 October 2022 adopted by the Italian Ministry of University and Research, Project title "One Health Basic and Translational Actions Addressing Unmet Needs on Emerging Infectious Diseases (INF-ACT)".


Funded by the European Union - NextGenerationEU Program
    MUR PNRR    PNRR Italia Domani




Copyright 2023 INF-ACT Foundation - All rights reserved

twitter:@fondaz_inf_act   linkedin:@fondazione-inf-act